Vázquez MA

Idioma: Español
Referencias bibliográficas: 71
Paginas:
Archivo PDF: 260.99 Kb.

RESUMEN

La presente revisión aborda algunas teorías existentes en el ámbito científico que tratan de explicar las diferencias de género en la depresión. Se exponen los criterios y hallazgos de diversos investigadores; así como algunas explicaciones y limitaciones de los artículos publicados. Todos los investigadores coinciden en que las tasas de prevalencia son mayores en mujeres, pero no existe consenso para las tasas de recurrencia que parecen ser iguales en ambos sexos. Algunos factores biológicos, fundamentalmente genéticos y hormonales tratan de explicar estas diferencias. Las mujeres están expuestas a mayor cantidad de estresores psicosociales y parecen ser más vulnerables al efecto depresogénico de estos. La respuesta al tratamiento antidepresivo varía para ambos sexos; estudios recientes reportan que los hombres responden mejor a los antidepresivos tricíclicos; mientras las mujeres tienen respuestas más favorables a los inhibidores selectivos de la recaptación de serotonina.

REFERENCIAS (EN ESTE ARTÍCULO)

1. New Understanding, New Hope. Geneva: World Health Organization; 2001.

2. Demir T, Karacetin G, Demir DE, Uysal O. Epidemilogy of depression in an urban population of Turkish children and adolescents. J Affect Dis 2011; 134:168-76.

3. APA. Quick Reference of the Diagnostic Criteria from DSM-IV. Washington DC, American Psychiatric Association; 1994.

4. Hammen C, Brennan PA, Keenan-Miller D, Hazel NA, Najman JM. Chronic and acute stress, gender, and serotonin transporter gene–environment interactions predicting depression symptoms in youth. J Child Psychol Psychiatr 2010; 51(2): 180-87.

5. Harkness KL, Alavi N, Monroe SM, Slavich GM, Gotlib IH, Bagby RM. Gender differences in life events prior to onset of major depressive disorder: The moderating effect of age. J Abnorm Psychol 2012; 119(4): 791-803.

6. Keers R, Aitchison KJ. Gender differences in antidepressant drug response. Int Rev Psychiatr 2010; 22(5):485-500.

7. Piccinelli M, Wilkinson G. Gender differences in depression. Br J Psychiatr 2000; 177:486-92.

8. García-Portilla MP. Depression and perimenopause: a review. Actas Esp Psiquiatr 2009; 37(4):213-21.

9. Guavita Falla PM, Sanabria Ferrand PA. Prevalencia de sintomatología depresiva en una población estudiantil de la Facultad de Medicina de la Universidad Militar Nueva Granada, Bogotá Colombia. Rev Fac Med Univ Nac Colombia 2006; 54(2):76-87.

10. Wang JK, Su TP, Chou P. Sex differences in prevalence and risk indicators of geriatric depression: the Shih – Pai community-based survey. J Formos Med Assoc 2010; 109(5):345-53.

11. Gourion D. Events of life and links with severe depression at different ages. Encephale 2009; 35(7):250-56.

12. Vázquez Machado A. Factores psicosociales asociados a la depresión. Rev Cienc Salud 2007; 1(1):5-11.

13. Davis KL, Charney D, Coyle JT, Nemeroff C. Neuropsychopharmacology: The fifth generation of progress. Philadelphia: Williams & Wilkins; 2002.

14. Young E, Korszun A. Sex, trauma, stress hormones and depression. Mol Psychiatr 2010; 15:23–8.

15. Kurzthaler I, Sperner-Unterweger B. Special gender issues in psychiatry. Acta Neuropsychiatr 2009; 21(Suppl2):1–72.

16. Lau JYF, Eley TC. Attributional style as a risk marker of genetic effects for adolescent depressive symptoms. J Abnorm Psychol 2008; 117(4):849-59.

17. Benjet C, Borges G, Medina-Mora ME, Méndez E, Fleiz C, Rojas E; et al. Diferencias de sexo en la prevalencia y severidad de trastornos psiquiátricos en adolescentes de la Ciudad de México. Salud Ment 2009; 31:155-63.

18. Tieman W, Van der Ende J, Verhulst FC. Psychiatric disorders in young adult intercountry adoptees: An epidemiological study. Am J Psychiatr 2005; 162:592-98?.

19. Silva H. Nuevas perspectivas en la biología de la depresión. Rev Chil Neuro-Psiquiat 2002;40(supl 1):9-20.

20. Galli E. La Depresión: Hacia una nueva conceptualización dimensional. Alcmeón 1997; 6(2):148-55.

21. Al-Otaibi B, Al-Wegayyan A, Taher H, Sarkhou E, Gloom A, Aseeri F. Depressive symptoms among kuwaití population attending primary healthcare setting: prevalence and influence of sociodemographic factors. Med Princ Practice 2007; 16(5):384-88.

22. González-Forteza C, Solís Torres C, Jiménez Tapia A, Hernández Fernández I, González-González A, Juárez García F; et al. Confiabilidad y validez de la escala de depresión CES-D en un censo de estudiantes de nivel medio superior y superior, en la Ciudad de México. Salud Ment 2011; 34(1):53-9.

23. Belló M, Puentes-Rosas E, Medina-Mora ME, Lozano R. Prevalencia y diagnóstico de depresión en población adulta en México. Salud Publ Mex 2005; 47(supl 1):4-11.

24. Kaplan G, Glasser S, Murad H, Atamna A, Alpert G, Goldbourt U; et al. Depression among Arabs and Jews in Israel: a population-based study. Soc Psychiat Epidemiol 2010;45:931–39.

25. Shansky RM. Estrogen, stress and the brain: progress toward unraveling gender discrepancies in major depressive disorder. Expert Rev Neurother 2009;9(7):967-73.

26. Essau CA, Lewinsohn PM, Seeley JR, Sasagawa S. Gender differences in the developmental course of depression. J Affect Disord 2010; 127:185–190.

27. Mori N, Caballero J. Historia natural de la depresión. Rev Peru Epidemiol 2010; 14 (2): 86-90.

28. Farmer A, Korszun A, Michael J, Gray J, Jones I, Jones L. Medical disorders in people with recurrent depression. Br J Psychiatr 2008; 192:351-55.

29. Essau CA. Course and outcome of major depressive disorder in non-referred adolescents. J Affect Dis 2007; 99:191–201.

30. Steunenberg B, Braam AW, Beekman ATF, Deeg DJH, Kerkhof, AJFM. Evidence for an association of the big five personality factors with recurrence of depressive symptoms in later life. Int J Geriat Psychiatr 2009; 24:1470–77.

31. Burcusa SL, Iacono WG. Risk for recurrence in depression. Clin Psychol Rev 2007; 27:959–85.

32. Suija K, Aluoja A, Kalda R, Maaroos HI. Factors associated with recurrent depression: a prospective study in family practice. Fam Practic 2010; 0:1-7.

33. Luijendijk HJ, van den Berg JF, Dekker MJ, van Tuijl HR, Otte W, Smit F; et al. Incidence and recurrence of late-life depression. Arch Gen Psychiatry 2008; 65(12):1394-401.

34. Kornstein SG, Schatzberg AF, Thase ME, Yonkers KA, McCullough JP, Keitner GI; et al. Gender Differences in Treatment Response to Sertraline Versus Imipramine in Chronic Depression. Am J Psychiatry 2000; 157:1445-52.

35. Janzing JGE, De Graaf R, ten Have M, Vollebergh WA, Verhagen M, Buitelaar JK. Familiality of depression in the community; associations with gender and phenotype of major depressive disorder. Soc Psychiat Epidemiol 2009; 44:1067–74.

36. Szatkowski JC. Causes of gender differences in depression. J Science: Winter; 2000.

37. Kuehner C. Gender differences in unipolar depression: an update of epidemiological findings and possible explanations. Acta Psychiatr Scand 2003:108: 163–174.

38. Agrawal A, Jacobson KC, Gardner CO, Prescott CA, Kendler KS. A population based twin study of sex differences in depressive symptoms. Twin Res 2004; 7(2):176-81.

39. Baghai T, Möller HJ, Rupprecht R. Recent Progress in Pharmacological and Non-Pharmacological Treatment Options of Major Depression. Current Pharmaceutical Design 2006; 12:503-515.

40. Xu Y, Li F, Huang X, Sun N, Zhang F, Liu P; et al. The norepinephrine transporter gene modulates the relationship between urban/rural residency and major depressive disorder in a Chinese population. Psychiatry Res 2009; 168(3):213-7.

41. Hyde JS, Mezulis AH, Abramson LY. The ABCs of depression: integrating affective, biological, and cognitive models to explain the emergence of the gender difference in depression. Psychol Rev 2008; 115(2):291-313.

42. Zahn-Waxler C, Shirtcliff EA, Marceau K. Disorders of childhood and adolescence: gender and psychopathology. Annu Rev Clin Psychol 2008; 4:11.1-11.29.

43. Hankin BJ, Mermelstein R, Roesch L. Sex differences in adolescent depression: Stress exposure and reactivity models. Child Dev 2007; 78(1)279-95.

44. Young EA, Altemus M. Puberty, ovarian steroids, and stress. Ann N Y Acad Sci 2004; 1021:124-133.

45. Pavía Ruz N, Civeira González L, Rosado Franco A. Síndrome disfórico premenstrual de docentes preescolares en Mérida, Yucatán. Ginecol Obstet Mex 2009; 77(4):185-90.

46. Strkalj Ivezić S, Kusan Jukić M, Tikvica A, Pavicić Baldani D. Diagnostic and therapeutic algorithm for the treatment of premenstrual dysphoric disorder. Acta Med Croatica 2010; 64(3):183-90.

47. Cunningham J, Yonkers KA, O'Brien S, Eriksson E. Update on research and treatment of premenstrual dysphoric disorder. Harv Rev Psychiatry 2009; 17(2):120-37.

48. Dietz PM, Williams SB, Callaghan WM, Bachman DJ, Whitlock EP, Hornbrook MC. Clinically Identified Maternal Depression Before, During, and After Pregnancies Ending in Live Births. Am J Psychiatry 2007; 164:1515-20.

49. Marcus SM. Depression during pregnancy: rates, risks and consequences—Motherisk Update 2008. Can J Clin Pharmacol 2009; 16(1):15-22.

50. Hirst KP, Moutier CY. Postpartum major depression 2010; 82(8):926-33.

51. Le Strat Y, Dubertret C, Le Foll B. Prevalence and correlates of major depressive episode in pregnant and postpartum women in the United States. J Affect Disord 2011; 135:128-38.

52. Paulson JF, Bazemore SD. Prenatal and postpartum depression in fathers and its association with maternal depression. A meta-analysis. JAMA 2010; 303(19):1961-69.

53. Rojas G, Fritsch R, Guajardo V, Rojas F, Barroilhet S, Jadresic E. Caracterización de madres deprimidas en el posparto. Rev Med Chile 2010; 138:536-42.

54. Leigh B, Milgrom J. Risk factors for antenatal depression, postnatal depression and parenting stress. BMC Psychiatry 2008; 8:24-37.

55. Wissart J, Parshad O, Kulkarni S. Prevalence of pre – and postpartum depression in Jamaican women. BMC Pregnancy Childbirth 2005; 5:15.

56. Parry BL. Optimal management of perimenopausal depression. Int J Womens Health. 2010; 9(2):143-51.

57. Schmidt PJ, Rubinow DR. Sex hormones and mood in the perimenopause. Ann N Y Acad Sci 2009; 1179:70-85.

58. Soares CN, Almeida OP, Joffe H, Cohen LS. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women. A double-blind, randomized, placebo-controlled trial. Arch Gen Psychiatry 2001; 58:529-34.

59. Flores Ramos M, Ontiveros Uribe M. Hormonas gonadales y depresión en la perimenopausia. Rev Colomb Psiquiat 2008; 37(2):236-46.

60. Freeman EW. Associations of depression with the transition to menopause. Menopause 2010; 17(4):823-27.

61. Sun MK, Alkon DL. Differential Gender-Related vulnerability to depression induction and converging antidepressant responses in rats. International J Behav Development 2004; 28(1):16-25.

62. Zarrouf FA, Artz S, Griffith J, Sirbu C, Kommor M. Testosterone and depression: systematic review and meta-analysis. J Psychiat Practice 2009; 15(4):289-305.

63. Jabbi M, Korf J, Ormel J, Kema IP, den Boer J. Stress, neurotransmitters and hormones. Investigating the molecular basis of major depressive disorder etiology a functional convergent genetic approach. Ann N Y Acad 2008; 1148:42-56.

64. Autry AE, Adachi M, Cheng P, Monteggia LM. Gender-specific impact of brain-derived neurotrophic factor signaling on stress-induced depression-like behavior. Biol Psychiatry 2009; 66(1):84-90.

65. Kim JM, Stewart R, Kim SW, Yang SJ, Shin IS, Kim YH; et al. Interactions between life stressors and susceptibility genes (5-HTTLPR and BDNF) on depression in korean elders. Biol Psychiatr 2007; 62:423–428.

66. Vázquez Machado A. Relación entre violencia y depresión en mujeres. Rev Neuropsiquiatr 2007; 70(1-4): 88 – 95.

67. Ghassemi GR, Sadeghi S, Asadollahi GA, Yousefy AR, Mallik S. Early experiences of abuse and current depressive disorders in Iranian women. EMHJ 2010; 6(5): 498-504.

68. Dalla C, Pitychoutis PM, Kokras N, Papadopoulou-Daifoti Z. Sex differences in animal models of depression and antidepressant response. Basic Clin Pharmacol Toxicol. 2010; 106(3):226-33.

69. Kecskés I, Rihmer Z, Szádóczky E, Füredi J, Kiss K. ¿Influyen el sexo y la ansiedad en el resultado del tratamiento de la Depresión? Eur J Psychiat (Ed. esp.) 2003; 17(1):17-21.

70. Smits KM, Smits LJ, Peeters FP, Schouten JS, Janssen RG, Smeets HJ; et al. The influence of 5-HTTLPR and STin2 polymorphisms in the serotonin transporter gene on treatment effect of selective serotonin reuptake inhibitors in depressive patients. Psychiatr Genet 2008; 18(4):184-90.

71. Watson HJ, Nathan PR. Role of gender in depressive disorder outcome for individual and group cognitive – behavioral treatment. J Clin Psychol 2008; 64(12):1323-37.